Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Andriol in Symptomatic Aging Men With Androgen Deficiency
NCT00434824Phase 2Completed
- Sponsor
- Merck & Co.
- Start
- Nov 2001
- Primary completion
- Jul 2004
- Modality
- Hormone, Biologic
01
Overview
A Phase 2 trial of testosterone undecanoate in Hypogonadism, sponsored by Merck & Co.. Started Nov 2001; status: completed.
02
Drugs
testosterone undecanoate
03
Conditions
Hypogonadism
Beyond the preview
Go deeper on NCT00434824.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00434824.